(Q38004984)

26 August 2017

Guidelines for the evaluation and management of status epilepticus (English)

1 reference

26 August 2017

1 reference

12

Paul M Vespa

1 reference

26 August 2017

10

Michael R Sperling

1 reference

26 August 2017

Gretchen M Brophy

1

0 references

Lori Shutter

object named as

Lori Shutter

9

0 references

Thomas P Bleck

object named as

Thomas P Bleck

5

0 references

David M Treiman

11

object named as

David M Treiman

1 reference

26 August 2017

Rodney Bell

2

1 reference

26 August 2017

Jan Claassen

3

1 reference

26 August 2017

Brian Alldredge

4

1 reference

26 August 2017

Tracy Glauser

6

1 reference

26 August 2017

Suzette M Laroche

7

1 reference

26 August 2017

James J Riviello

8

1 reference

26 August 2017

Neurocritical Care Society Status Epilepticus Guideline Writing Committee

13

1 reference

26 August 2017

1 August 2012

1 reference

26 August 2017

1 reference

26 August 2017

17

1 reference

26 August 2017

1

1 reference

26 August 2017

3-23

1 reference

https://scigraph.springernature.com/pub.10.1007/s12028-012-9695-z

26 August 2017

0 references

cites work

An alternative perspective on the management of status epilepticus.

1 reference

https://api.crossref.org/works/10.1007%2FS12028-012-9695-Z

Problems and controversies in status epilepticus: a review and recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-012-9695-Z

Management of refractory status epilepticus in adults: still more questions than answers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-012-9695-Z

American College of Cardiology/American Heart Association clinical practice guidelines: Part I: where do they come from?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-012-9695-Z

Use of EEG monitoring and management of non-convulsive seizures in critically ill patients: a survey of neurologists

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-012-9695-Z

How long do most seizures last? A systematic comparison of seizures recorded in the epilepsy monitoring unit

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-012-9695-Z

Physiology of Status Epilepticus in Primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-012-9695-Z

Status epilepticus: pathophysiology and management in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-012-9695-Z

Time-dependent decrease in the effectiveness of antiepileptic drugs during the course of self-sustaining status epilepticus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-012-9695-Z

Status epilepticus: an overview of the clinical problem

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-012-9695-Z

Status epilepticus: a critical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-012-9695-Z

A comparison of lorazepam, diazepam, and placebo for the treatment of out-of-hospital status epilepticus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-012-9695-Z

EFNS guideline on the management of status epilepticus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-012-9695-Z

Status epilepticus: an evidence based guide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-012-9695-Z

Nonconvulsive status epilepticus in the emergency room.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-012-9695-Z

What is nonconvulsive status epilepticus, and what are its subtypes?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-012-9695-Z

Prevalence of nonconvulsive status epilepticus in comatose patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-012-9695-Z

Propofol treatment of refractory status epilepticus: a study of 31 episodes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-012-9695-Z

Depth of EEG suppression and outcome in barbiturate anesthetic treatment for refractory status epilepticus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-012-9695-Z

Continuous EEG monitoring and midazolam infusion for refractory nonconvulsive status epilepticus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-012-9695-Z

A comparison of four treatments for generalized convulsive status epilepticus. Veterans Affairs Status Epilepticus Cooperative Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-012-9695-Z

Nonconvulsive seizures: developing a rational approach to the diagnosis and management in the critically ill population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-012-9695-Z

Refractory status epilepticus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-012-9695-Z

In whom does status epilepticus occur: age-related differences in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-012-9695-Z

Practice parameter: diagnostic assessment of the child with status epilepticus (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-012-9695-Z

Prognosis of status epilepticus: role of aetiology, age, and consciousness impairment at presentation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-012-9695-Z

Oral pregabalin as an add-on treatment for status epilepticus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-012-9695-Z

Short-term mortality after a first episode of status epilepticus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-012-9695-Z

Functional outcome after convulsive status epilepticus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-012-9695-Z

The treatment of status epilepticus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-012-9695-Z

Causes and consequences of status epilepticus in adults. A study of 86 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-012-9695-Z

Status epilepticus at an urban public hospital in the 1980s

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-012-9695-Z

Generalized convulsive status epilepticus: causes, therapy, and outcome in 346 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-012-9695-Z

Generalized convulsive status epilepticus management in adults: a cohort study with evaluation of professional practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-012-9695-Z

Assessment of acute morbidity and mortality in nonconvulsive status epilepticus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-012-9695-Z

Persistent nonconvulsive status epilepticus after the control of convulsive status epilepticus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-012-9695-Z

Pentobarbital treatment of refractory status epilepticus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-012-9695-Z

Treatment of refractory generalized tonic-clonic status epilepticus with pentobarbital anesthesia after high-dose phenytoin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-012-9695-Z

Pentobarbital and EEG burst suppression in treatment of status epilepticus refractory to benzodiazepines and phenytoin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-012-9695-Z

Prognostic factors of pentobarbital therapy for refractory generalized status epilepticus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-012-9695-Z

Generalized tonic-clonic status epilepticus: causes, treatment, complications and predictors of case fatality.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-012-9695-Z

Role of propofol in refractory status epilepticus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-012-9695-Z

Treatment of refractory status epilepticus with propofol: clinical and pharmacokinetic findings.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-012-9695-Z

Treatment of refractory status epilepticus with pentobarbital, propofol, or midazolam: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-012-9695-Z

Duration of refractory status epilepticus and outcome: loss of prognostic utility after several hours

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-012-9695-Z

Predictors and prognosis of refractory status epilepticus treated in a neurological intensive care unit

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-012-9695-Z

Refractory status epilepticus: effect of treatment aggressiveness on prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-012-9695-Z

Detection and treatment of refractory status epilepticus in the intensive care unit.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-012-9695-Z

A randomized trial for the treatment of refractory status epilepticus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-012-9695-Z

Convulsive status epilepticus in children: etiology, treatment protocol and outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-012-9695-Z

Outcome of severe refractory status epilepticus in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-012-9695-Z

Prolonged treatment for acute symptomatic refractory status epilepticus: outcome in children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-012-9695-Z

Efficacy and mortality in treatment of refractory generalized convulsive status epilepticus in children: a meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-012-9695-Z

Refractory status epilepticus: frequency, risk factors, and impact on outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-012-9695-Z

Determinants of mortality in status epilepticus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-012-9695-Z

Emergency management of pediatric convulsive status epilepticus: a multicenter study of 542 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-012-9695-Z

Airway management in neurological emergencies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-012-9695-Z

EEG detection of nontonic-clonic status epilepticus in patients with altered consciousness.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-012-9695-Z

Presentation, evaluation, and treatment of nonconvulsive status epilepticus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-012-9695-Z

Continuous electroencephalography in the medical intensive care unit.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-012-9695-Z

Double-blind Study of Lorazepam and Diazepam in Status Epilepticus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-012-9695-Z

Intramuscular versus intravenous therapy for prehospital status epilepticus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-012-9695-Z

Dissolving oral clonazepam wafers in the acute treatment of prolonged seizures

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-012-9695-Z

Treatment of seizure emergencies: convulsive and non-convulsive status epilepticus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-012-9695-Z

Lorazepam in status epilepticus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-012-9695-Z

A comparison of lorazepam and diazepam as initial therapy in convulsive status epilepticus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-012-9695-Z

Prehospital Treatment of Status Epilepticus with Benzodiazepines Is Effective and Safe

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-012-9695-Z

Treatment of convulsive status epilepticus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-012-9695-Z

Anticonvulsant therapy for status epilepticus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-012-9695-Z

Lorazepam versus diazepam for the treatment of status epilepticus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-012-9695-Z

Lorazepam versus diazepam-phenytoin combination in the treatment of convulsive status epilepticus in children: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-012-9695-Z

Comparative audit of intravenous lorazepam and diazepam in the emergency treatment of convulsive status epilepticus in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-012-9695-Z

Midazolam versus diazepam for the treatment of status epilepticus in children and young adults: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-012-9695-Z

Buccal midazolam or rectal diazepam for treatment of residential adult patients with serial seizures or status epilepticus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-012-9695-Z

A comparison of buccal midazolam and rectal diazepam for the acute treatment of seizures

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-012-9695-Z

Comparison of intranasal midazolam with intravenous diazepam for treating febrile seizures in children: prospective randomised study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-012-9695-Z

Safety and efficacy of buccal midazolam versus rectal diazepam for emergency treatment of seizures in children: a randomised controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-012-9695-Z

Buccal midazolam and rectal diazepam for treatment of prolonged seizures in childhood and adolescence: a randomised trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-012-9695-Z

Comparison of intranasal midazolam with intravenous diazepam for treating acute seizures in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-012-9695-Z

Midazolam as a first-line agent for status epilepticus in children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-012-9695-Z

Status epilepticus: clinical analysis of a treatment protocol based on midazolam and phenytoin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-012-9695-Z

Continuous midazolam infusion as treatment of status epilepticus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-012-9695-Z

Parenteral diazepam in status epilepticus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-012-9695-Z

Use of diazepam in treatment of severe convulsive status epilepticus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-012-9695-Z

Rectal diazepam for prehospital pediatric status epilepticus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-012-9695-Z

Status epilepticus in infants and young children treated with parenteral diazepam

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-012-9695-Z

Treatment of status epilepticus: a prospective comparison of diazepam and phenytoin versus phenobarbital and optional phenytoin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-012-9695-Z

Treatment of convulsive status epilepticus in infants and young children in Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-012-9695-Z

Treatment of status epilepticus and acute repetitive seizures with i.v. valproic acid vs phenytoin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-012-9695-Z

Phenytoin, levetiracetam, and pregabalin in the acute management of refractory status epilepticus in patients with brain tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-012-9695-Z

Efficacy of rapid IV administration of valproic acid for status epilepticus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-012-9695-Z

Intravenous valproate as an innovative therapy in seizure emergency situations including status epilepticus--experience in 102 adult patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-012-9695-Z

Intravenous levetiracetam as treatment for status epilepticus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-012-9695-Z

Two years of experience in the treatment of status epilepticus with intravenous levetiracetam.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-012-9695-Z

Intravenous levetiracetam for epileptic seizure emergencies in older people

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-012-9695-Z

Intravenous levetiracetam: treatment experience with the first 50 critically ill patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-012-9695-Z

Levetiracetam as a treatment option in non-convulsive status epilepticus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-012-9695-Z

Intravenous Levetiracetam as first-line treatment of status epilepticus in the elderly.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-012-9695-Z

Intravenous levetiracetam in critically ill children with status epilepticus or acute repetitive seizures

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-012-9695-Z

Safety and pharmacokinetics of intravenous levetiracetam infusion as add-on in status epilepticus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-012-9695-Z

Safety and Efficacy of Intravenous Valproate in Pediatric Status Epilepticus and Acute Repetitive Seizures

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-012-9695-Z

Intravenous sodium valproate in mainland China for the treatment of diazepam refractory convulsive status epilepticus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-012-9695-Z

Valproate is an effective, well-tolerated drug for treatment of status epilepticus/serial attacks in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-012-9695-Z

Treatment of community-onset, childhood convulsive status epilepticus: a prospective, population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-012-9695-Z

Barbiturate anesthesia in the treatment of status epilepticus: clinical experience with 14 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-012-9695-Z

Intravenous levetiracetam: a new treatment alternative for refractory status epilepticus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-012-9695-Z

Experience with intravenous levetiracetam in status epilepticus: a retrospective case series

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-012-9695-Z

Continuous midazolam versus diazepam infusion for refractory convulsive status epilepticus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-012-9695-Z

Efficacy of continuous midazolam infusion and mortality in childhood refractory generalized convulsive status epilepticus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-012-9695-Z

Propofol and midazolam in the treatment of refractory status epilepticus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-012-9695-Z

Continuous infusion of midazolam in the treatment of refractory generalized convulsive status epilepticus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-012-9695-Z

Midazolam coma for refractory status epilepticus in children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-012-9695-Z

High-dose midazolam therapy for refractory status epilepticus in children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-012-9695-Z

Continuous propofol infusion in 142 critically ill children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-012-9695-Z

Predictors of mortality in patients with suspected propofol infusion syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-012-9695-Z

Propofol in the treatment of refractory status epilepticus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-012-9695-Z

Propofol and thiopental for refractory status epilepticus in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-012-9695-Z

Propofol infusion syndrome in patients with refractory status epilepticus: an 11-year clinical experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-012-9695-Z

Relapse and survival after barbiturate anesthetic treatment of refractory status epilepticus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-012-9695-Z

Ten patients with refractory status epilepticus in an intensive care department.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-012-9695-Z

Management of refractory status epilepticus at a tertiary care centre in a developing country

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-012-9695-Z

Intravenous sodium valproate versus diazepam infusion for the control of refractory status epilepticus in children: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-012-9695-Z

Intravenous valproate in pediatric epilepsy patients with refractory status epilepticus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-012-9695-Z

Intravenous levetiracetam in the treatment of benzodiazepine refractory status epilepticus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-012-9695-Z

The use of levetiracetam in refractory status epilepticus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-012-9695-Z

Levetiracetam in children with refractory status epilepticus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-012-9695-Z

Reassessment of phenytoin for treatment of late stage progressive myoclonus epilepsy complicated with status epilepticus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-012-9695-Z

Intravenous lacosamide--an effective add-on treatment of refractory status epilepticus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-012-9695-Z

The use of topiramate in refractory status epilepticus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-012-9695-Z

Generalized convulsive status epilepticus in adults and children: treatment guidelines and protocols.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-012-9695-Z

Which anesthetic should be used in the treatment of refractory status epilepticus?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-012-9695-Z

The treatment of super-refractory status epilepticus: a critical review of available therapies and a clinical treatment protocol

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-012-9695-Z

Very-high-dose phenobarbital for childhood refractory status epilepticus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-012-9695-Z

Now we lay them down to sleep: ethical issues with the use of pharmacologic coma for adult status epilepticus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-012-9695-Z

Prolonged coma from refractory status epilepticus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-012-9695-Z

Severe refractory status epilepticus owing to presumed encephalitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-012-9695-Z

Oral ketamine in paediatric non-convulsive status epilepticus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-012-9695-Z

Adrenocorticotropic hormone versus pulsatile dexamethasone in the treatment of infantile epilepsy syndromes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-012-9695-Z

Treatment of refractory status epilepticus with inhalational anesthetic agents isoflurane and desflurane

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-012-9695-Z

Vagus nerve stimulation (VNS) is effective in treating catastrophic 1 epilepsy in very young children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-012-9695-Z

Treatment of refractory status epilepticus: literature review and a proposed protocol

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-012-9695-Z

Efficacy of ketogenic diet in severe refractory status epilepticus initiating fever induced refractory epileptic encephalopathy in school age children (FIRES).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-012-9695-Z

Hypothermia for refractory status epilepticus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-012-9695-Z

Electroconvulsive therapy for refractory status epilepticus: a case series

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-012-9695-Z

Seizure suppression by EEG-guided repetitive transcranial magnetic stimulation in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-012-9695-Z

Epilepsy surgery in children with electrical status epilepticus in sleep

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-012-9695-Z

Resective surgery to treat refractory status epilepticus in children with focal epileptogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-012-9695-Z

Neurosurgical treatment of medically intractable status epilepticus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-012-9695-Z

Predictors of awakening from postanoxic status epilepticus after therapeutic hypothermia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-012-9695-Z

Continuous amplitude-integrated electroencephalogram predicts outcome in hypothermia-treated cardiac arrest patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-012-9695-Z

What is the value of hypothermia in acute neurologic diseases and status epilepticus?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-012-9695-Z

Super-refractory status epilepticus: an approach to therapy in this difficult clinical situation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-012-9695-Z

Practice parameter update: management issues for women with epilepsy--focus on pregnancy (an evidence-based review): obstetrical complications and change in seizure frequency: report of the Quality Standards Subcommittee and Therapeutics and Technol

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-012-9695-Z

Emergency department approach to managing seizures in pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-012-9695-Z

Neurologic disorders in pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-012-9695-Z

Newer-Generation Antiepileptic Drugs and the Risk of Major Birth Defects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-012-9695-Z

The treatment of convulsive status epilepticus in children. The Status Epilepticus Working Party, Members of the Status Epilepticus Working Party

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-012-9695-Z

Refractory status epilepticus in children: role of continuous diazepam infusion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-012-9695-Z

Increased incidence and impact of nonconvulsive and convulsive seizures after traumatic brain injury as detected by continuous electroencephalographic monitoring

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-012-9695-Z

Detection of electrographic seizures with continuous EEG monitoring in critically ill patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-012-9695-Z

Digital video-electroencephalographic monitoring in the neurological-neurosurgical intensive care unit: clinical features and outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-012-9695-Z

Acute seizures after intracerebral hemorrhage: a factor in progressive midline shift and outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-012-9695-Z

Early EEG monitoring for detecting postanoxic status epilepticus during therapeutic hypothermia: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-012-9695-Z

Nonconvulsive seizures are common in critically ill children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-012-9695-Z

New chronic EEG electrode for critical/intensive care unit monitoring.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-012-9695-Z

Continuous EEG monitoring for the detection of seizures in traumatic brain injury, infarction, and intracerebral hemorrhage: "to detect and protect".

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-012-9695-Z

Increase in extracellular glutamate caused by reduced cerebral perfusion pressure and seizures after human traumatic brain injury: a microdialysis study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-012-9695-Z

Persistently low extracellular glucose correlates with poor outcome 6 months after human traumatic brain injury despite a lack of increased lactate: a microdialysis study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-012-9695-Z

Nonconvulsive seizures after traumatic brain injury are associated with hippocampal atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-012-9695-Z

Treatment of status epilepticus: a survey of neurologists

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-012-9695-Z

Status epilepticus increases the intracellular accumulation of GABAA receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-012-9695-Z

Trafficking of GABA(A) receptors, loss of inhibition, and a mechanism for pharmacoresistance in status epilepticus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-012-9695-Z

Impact of receptor changes on treatment of status epilepticus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-012-9695-Z

Excitatory amino acids in epilepsy and potential novel therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-012-9695-Z

A comparison of three NMDA receptor antagonists in the treatment of prolonged status epilepticus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-012-9695-Z

Clinical relevance of cortical spreading depression in neurological disorders: migraine, malignant stroke, subarachnoid and intracranial hemorrhage, and traumatic brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-012-9695-Z

Spreading depolarizations have prolonged direct current shifts and are associated with poor outcome in brain trauma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-012-9695-Z

Spreading depolarizations occur in human ischemic stroke with high incidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-012-9695-Z

Delayed ischaemic neurological deficits after subarachnoid haemorrhage are associated with clusters of spreading depolarizations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-012-9695-Z

Spreading convulsions, spreading depolarization and epileptogenesis in human cerebral cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-012-9695-Z

Association of seizures with cortical spreading depression and peri-infarct depolarisations in the acutely injured human brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-012-9695-Z

Intracortical electroencephalography in acute brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-012-9695-Z

The EEG and prognosis in status epilepticus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-012-9695-Z

Use of serum prolactin in diagnosing epileptic seizures: Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-012-9695-Z

Serum neuron-specific enolase in the major subtypes of status epilepticus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-012-9695-Z

Outcomes in 140 critically ill patients with status epilepticus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-012-9695-Z

Experience with immunomodulatory treatments in Rasmussen's encephalitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-012-9695-Z

Eight-year study of childhood status epilepticus: midazolam infusion in management and outcome

21 January 2018

1 reference

12 December 2020

Continuous EEG monitoring in the intensive care unit: an overview.

1 reference

12 December 2020

The role of benzodiazepines in the management of status epilepticus.

1 reference

12 December 2020

How long do new-onset seizures in children last?

1 reference

12 December 2020

Magnesium sulphate versus phenytoin for eclampsia

1 reference

12 December 2020

Treatment of status epilepticus

1 reference

12 December 2020

The role of ketogenic diet in the treatment of refractory status epilepticus

1 reference

12 December 2020

Functional and cognitive outcome in prolonged refractory status epilepticus

1 reference

12 December 2020

Treatment of convulsive status epilepticus in infants and young children in Japan.

1 reference

12 December 2020

Neurosurgical treatment of status epilepticus

1 reference

12 December 2020

The prevalence of seizures in comatose children in the pediatric intensive care unit: a prospective video-EEG study

1 reference

12 December 2020

Recovery from near drowning and postanoxic status epilepticus with controlled hypothermia

1 reference

12 December 2020

Very-high-dose phenobarbital for refractory status epilepticus in children

1 reference

12 December 2020

The revised operational definition of generalised tonic-clonic (TC) status epilepticus in adults

1 reference

12 December 2020

Emergent electroencephalogram in the intensive care unit: indications and diagnostic yield

1 reference

12 December 2020

Use of antiepileptic drugs in the treatment of epilepsy in people with intellectual disability

1 reference

12 December 2020

The Use of Lacosamide in Refractory Status Epilepticus

1 reference

12 December 2020

Nonconvulsive electrographic seizures after traumatic brain injury result in a delayed, prolonged increase in intracranial pressure and metabolic crisis

1 reference

12 December 2020

Use of GRADE grid to reach decisions on clinical practice guidelines when consensus is elusive

1 reference

12 December 2020

Time trends in incidence, mortality, and case-fatality after first episode of status epilepticus

1 reference

12 December 2020

Status epilepticus treated by barbiturate anaesthesia with continuous monitoring of cerebral function

1 reference

12 December 2020

Intravenous midazolam for the treatment of refractory status epilepticus.

1 reference

12 December 2020

Imaging Compatible Electrodes for Continuous Electroencephalogram Monitoring in the Intensive Care Unit

1 reference

12 December 2020

Hypothermia and barbiturate coma for refractory status epilepticus.

1 reference

12 December 2020

The secondarily generalized tonic-clonic seizure: a videotape analysis

1 reference

12 December 2020

Nonconvulsive status epilepticus in the critically ill elderly

1 reference

12 December 2020

1 reference

12 December 2020

High-dose intravenous lorazepam for the treatment of refractory status epilepticus

1 reference

12 December 2020

Lorazepam in childhood status epilepticus and serial seizures: effectiveness and tachyphylaxis

1 reference

12 December 2020

Nonconvulsive seizures among critically ill children: Look and you shall find

1 reference

12 December 2020

Long-term mortality after a first episode of status epilepticus

1 reference

12 December 2020

Status epilepticus arising de novo in hospitalized patients: an analysis of 41 patients

1 reference

12 December 2020

Status epilepticus. Causes, clinical features and consequences in 98 patients

1 reference

12 December 2020

Second-line status epilepticus treatment: comparison of phenytoin, valproate, and levetiracetam

1 reference

12 December 2020

Anesthetic barbiturates in refractory status epilepticus.

1 reference

12 December 2020

Incidence, cause, and short-term outcome of convulsive status epilepticus in childhood: prospective population-based study

1 reference

12 December 2020

Intravenous valproate is well tolerated in unstable patients with status epilepticus

1 reference

12 December 2020

Standards of care for adults with convulsive status epilepticus: Belgian consensus recommendations.

1 reference

12 December 2020

Midazolam in the treatment of status epilepticus in children.

1 reference

12 December 2020

Still orphans: Antiepileptic drug trials in children under 2 years of age

1 reference

12 December 2020

Lorazepam versus diazepam in the acute treatment of epileptic seizures and status epilepticus

1 reference

12 December 2020

Neurophysiologic monitoring in the neuroscience intensive care unit.

1 reference

12 December 2020

Low morbidity and mortality of status epilepticus in children

1 reference

12 December 2020

The ACNS Subcommittee on Research Terminology for Continuous EEG Monitoring: Proposed Standardized Terminology for Rhythmic and Periodic EEG Patterns Encountered in Critically Ill Patients

1 reference

12 December 2020

Sodium valproate vs phenytoin in status epilepticus: a pilot study

1 reference

12 December 2020

Randomized study of intravenous valproate and phenytoin in status epilepticus

1 reference

12 December 2020

Isoflurane for refractory status epilepticus: a clinical series

1 reference

12 December 2020

Vagus nerve stimulation for refractory epilepsy in children: More to VNS than seizure frequency reduction

1 reference

12 December 2020

Rapid seizure-induced reduction of benzodiazepine and Zn2+ sensitivity of hippocampal dentate granule cell GABAA receptors

1 reference

12 December 2020

Predictors of functional disability and mortality after status epilepticus

1 reference

12 December 2020

Prolonged pentobarbital and phenobarbital coma for refractory generalized status epilepticus

1 reference

12 December 2020

An assessment of nonconvulsive seizures in the intensive care unit using continuous EEG monitoring: an investigation of variables associated with mortality

1 reference

12 December 2020

1 reference

12 December 2020

Anticonvulsant therapy for status epilepticus

1 reference

12 December 2020

Intravenous lacosamide for treatment of status epilepticus

1 reference

12 December 2020

Treatment of status epilepticus with diazepam

1 reference

12 December 2020

The management of status epilepticus

1 reference

12 December 2020

10.1007/S12028-012-9695-Z

Identifiers

DOI

1 reference

Dimensions Publication ID

26 August 2017

1050454608

0 references

Fatcat ID

release_ll54zi6q4fbjfgutul5irhvocq

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/ll54zi6q4fbjfgutul5irhvocq

24 November 2022

mapped directly with Wikidata item

1 reference